Skip to main content

Closed

VIR: Vir Biotechnology, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-13.9% / yr

Operating margin-704.9%

ROIC-48.0%

Financially safe

Stretched

Debt / equity0.12×

Interest coverage0.0×

Current ratio7.11×

Vir Biotechnology, Inc.

VIRNASDAQ Global Select·USD·Closed

Vir Biotechnology, Inc.

VIRNASDAQ·USD·Closed

$8.66

−2.70%

$8.66

−$0.24 (2.70%)

52W Range

60thpctl

Volume

0.59×avg

Mkt Cap

1.46BUSD

P/E

-2.8TTM

Div Yield

–ann

52W Range

60thpctl

Volume

0.59×avg

Market Cap

1.46BUSD

P/E Ratio

-2.8TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings